WELL Health Technologies - WELL Stock Price Target and Predictions

  • Consensus Rating: Moderate Buy
  • Consensus Price Target: C$8.28
  • Forecasted Upside: 16.59%
  • Number of Analysts: 3
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
C$7.10
▲ +0.08 (1.14%)

This chart shows the closing price for WELL by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New WELL Health Technologies Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for WELL and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for WELL

Analyst Price Target is C$8.28
▲ +16.59% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for WELL Health Technologies in the last 3 months. The average price target is C$8.28, with a high forecast of C$11.00 and a low forecast of C$5.50. The average price target represents a 16.59% upside from the last price of C$7.10.

This chart shows the closing price for WELL for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Moderate Buy

The current consensus among 3 investment analysts is to moderate buy stock in WELL Health Technologies. This rating has held steady since October 2023, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 5 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/29/2023
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/27/2023
  • 0 strong buy ratings
  • 5 buy ratings
  • 1 hold ratings
  • 0 sell ratings
12/26/2023
  • 0 strong buy ratings
  • 5 buy ratings
  • 2 hold ratings
  • 0 sell ratings
3/25/2024
  • 0 strong buy ratings
  • 4 buy ratings
  • 2 hold ratings
  • 0 sell ratings
6/23/2024
  • 0 strong buy ratings
  • 4 buy ratings
  • 2 hold ratings
  • 0 sell ratings
9/21/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
11/20/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
12/20/2024

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
12/17/2024Raymond JamesBoost TargetC$10.00 ➝ C$11.00
12/17/2024TD SecuritiesBoost TargetC$8.00 ➝ C$8.50
12/16/2024ScotiabankBoost TargetC$6.00 ➝ C$7.00
12/13/2024CIBCBoost TargetC$5.25 ➝ C$7.00
12/13/2024Haywood SecuritiesBoost TargetC$8.00 ➝ C$10.00
11/8/2024CIBCBoost TargetC$5.00 ➝ C$5.25
10/29/2024Ventum FinancialLower TargetBuyC$8.00 ➝ C$7.00
8/16/2024CIBCBoost TargetC$4.75 ➝ C$5.00
4/29/2024Stifel NicolausLower TargetC$11.00 ➝ C$10.00
2/6/2024Royal Bank of CanadaSet TargetOutperformC$5.50
1/31/2024Pi FinancialBoost TargetC$8.25 ➝ C$8.50
1/22/2024CIBCDowngradeOutperform ➝ NeutralC$5.50 ➝ C$4.75
11/16/2023LaurentianLower TargetBuyC$9.00 ➝ C$6.50
11/15/2023DesjardinsLower TargetHoldC$5.50 ➝ C$5.25
11/15/2023TD SecuritiesLower TargetBuyC$8.50 ➝ C$8.00
11/15/2023Stifel NicolausLower TargetBuyC$12.00 ➝ C$11.00
8/11/2023CIBCLower TargetC$7.50 ➝ C$6.50
8/11/2023Haywood SecuritiesBoost TargetC$8.00 ➝ C$8.50
8/11/2023Pi FinancialBoost TargetC$7.75 ➝ C$8.25
8/11/2023Stifel NicolausLower TargetC$13.50 ➝ C$12.00
7/19/2023TD SecuritiesBoost TargetBuyC$7.50 ➝ C$8.50
7/14/2023CIBCBoost TargetC$7.00 ➝ C$7.50
5/17/2023Pi FinancialBoost TargetC$7.50 ➝ C$7.75
4/25/2023Raymond JamesSet TargetOutperformC$8.50
3/22/2023Canaccord Genuity GroupBoost TargetC$6.00 ➝ C$6.50
3/22/2023CIBCBoost TargetOutperformC$6.50 ➝ C$7.00
11/11/2022TD SecuritiesLower TargetBuyC$8.00 ➝ C$7.00
11/11/2022CIBCLower TargetOutperformC$7.00 ➝ C$6.50
11/3/2022ScotiabankLower TargetC$7.50 ➝ C$6.50
10/14/2022Maxim GroupReiterated RatingBuyC$9.00
10/12/2022CIBCLower TargetOutperformC$7.50 ➝ C$7.00
9/27/2022Maxim GroupReiterated RatingBuyC$9.00
9/15/2022Eight CapitalLower TargetBuyC$12.00 ➝ C$10.00
8/15/2022CIBCBoost TargetC$6.50 ➝ C$7.50
8/12/2022TD SecuritiesBoost TargetBuyC$7.00 ➝ C$8.00
5/20/2022CIBCLower TargetOutperformC$8.00 ➝ C$6.50
5/20/2022ScotiabankLower TargetC$9.00 ➝ C$7.50
5/20/2022Canaccord Genuity GroupLower TargetC$10.00 ➝ C$6.00
5/20/2022TD SecuritiesLower TargetBuyC$9.00 ➝ C$7.00
4/25/2022Haywood SecuritiesReiterated RatingBuyC$12.00
4/5/2022Eight CapitalLower TargetBuyC$13.00 ➝ C$12.00
4/4/2022Canaccord Genuity GroupLower TargetC$12.00 ➝ C$10.00
4/4/2022Pi FinancialLower TargetBuyC$10.50 ➝ C$9.00
1/25/2022CIBCLower TargetOutperformC$11.00 ➝ C$8.00
11/26/2021TD SecuritiesSet TargetBuyC$11.00
11/12/2021TD SecuritiesBoost TargetBuyC$10.50 ➝ C$11.00
11/12/2021CIBCBoost TargetC$10.50 ➝ C$11.00
11/2/2021CIBCLower TargetC$11.50 ➝ C$10.50
9/23/2021Echelon Wealth PartnersInitiated CoverageBuyC$13.00
9/3/2021CIBCBoost TargetOutperformC$11.00 ➝ C$11.50
8/16/2021CIBCReiterated RatingOutperformC$11.00
7/19/2021ScotiabankSet TargetSector PerformC$10.00
7/16/2021TD SecuritiesLower TargetBuyC$11.00 ➝ C$10.50
6/8/2021TD SecuritiesBoost TargetBuyC$9.50 ➝ C$11.00
6/8/2021CIBCBoost TargetOutperformC$9.00 ➝ C$11.00
5/12/2021TD SecuritiesLower TargetBuyC$10.50 ➝ C$9.50
5/12/2021CIBCReiterated RatingOutperformC$9.00
5/5/2021Pi FinancialReiterated RatingBuyC$10.50
4/26/2021CIBCReiterated RatingOutperformC$9.00
4/23/2021TD SecuritiesBoost TargetBuyC$10.00 ➝ C$10.50
3/19/2021TD SecuritiesLower TargetStrong-BuyC$11.00 ➝ C$10.00
2/19/2021Eight CapitalBoost TargetNAC$10.00 ➝ C$13.00
2/9/2021Laurentian Bank of CanadaBoost TargetC$10.75 ➝ C$12.50
2/9/2021LaurentianBoost TargetC$10.75 ➝ C$12.50
11/3/2020Pi FinancialSet TargetBuyC$9.35
10/23/2020Pi FinancialBoost TargetBuyC$7.00 ➝ C$9.35
9/29/2020Eight CapitalBoost TargetC$8.00 ➝ C$9.00
9/2/2020Pi FinancialBoost TargetBuyC$4.90 ➝ C$7.00
9/2/2020Eight CapitalBoost TargetC$5.00 ➝ C$8.00
8/10/2020Pi FinancialSet TargetBuyC$3.50
8/6/2020Eight CapitalBoost TargetC$4.25 ➝ C$5.00
7/21/2020DesjardinsReiterated RatingBuy
7/9/2020Pi FinancialReiterated RatingBuy
7/9/2020Pi FinancialBoost TargetBuyC$3.35 ➝ C$3.50
7/9/2020LaurentianBoost TargetC$3.25 ➝ C$3.50
7/7/2020Echelon Wealth PartnersReiterated RatingSpeculative Buy
5/25/2020Pi FinancialBoost TargetBuyC$2.05 ➝ C$3.35
4/1/2020Pi FinancialSet TargetBuyC$2.05
3/26/2020Pi FinancialSet TargetBuyC$2.05
3/19/2020Pi FinancialLower TargetC$2.45 ➝ C$2.05
2/13/2020Pi FinancialSet TargetC$2.45
2/7/2020Eight CapitalBoost TargetC$2.15 ➝ C$2.50
2/4/2020Pi FinancialSet TargetBuyC$2.20
1/29/2020LaurentianSet TargetBuyC$2.50
1/10/2020Pi FinancialBoost TargetC$1.80 ➝ C$2.20
(Data available from 12/21/2019 forward)

News Sentiment Rating

0.61 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 10 very positive mentions
  • 17 positive mentions
  • 2 negative mentions
  • 1 very negative mentions
5/25/2024
  • 2 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
6/24/2024
  • 5 very positive mentions
  • 10 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
7/24/2024
  • 12 very positive mentions
  • 27 positive mentions
  • 2 negative mentions
  • 2 very negative mentions
8/23/2024
  • 3 very positive mentions
  • 17 positive mentions
  • 7 negative mentions
  • 1 very negative mentions
9/22/2024
  • 6 very positive mentions
  • 35 positive mentions
  • 6 negative mentions
  • 2 very negative mentions
10/22/2024
  • 4 very positive mentions
  • 30 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
11/21/2024
  • 3 very positive mentions
  • 9 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/21/2024

Current Sentiment

  • 3 very positive mentions
  • 9 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
WELL Health Technologies logo
WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. It provides omni-channel patient services and solutions to specific markets, such as provider staffing, anesthesia, gastrointestinal health, women's health, primary care, and mental healthcare. The company also develops, integrates, and sells its own suite of technology software and technology solutions to medical clinics and healthcare practitioners. In addition, it operates practitioner enablement platform, including Electronic Medical Records (EMR); telehealth platforms; practice management; AI-powered virtual assistant (WELL AI Voice); Apps.health, a digital health app marketplace; billing and revenue cycle management solutions for billing and back-office services comprising billing-as-a-service outsourcing services to doctors; and cybersecurity protection and patient data privacy solutions, as well as OSCAR Pro, an EMR platform. The company was founded in 2010 and is headquartered in Vancouver, Canada.
Read More

Today's Range

Now: C$7.10
Low: C$6.92
High: C$7.17

50 Day Range

MA: C$5.40
Low: C$4.37
High: C$7.10

52 Week Range

Now: C$7.10
Low: C$3.41
High: C$7.19

Volume

881,260 shs

Average Volume

901,598 shs

Market Capitalization

C$1.77 billion

P/E Ratio

12.46

Dividend Yield

N/A

Beta

1.2

Frequently Asked Questions

What sell-side analysts currently cover shares of WELL Health Technologies?

The following Wall Street sell-side analysts have issued stock ratings on WELL Health Technologies in the last twelve months: CIBC, Haywood Securities, Pi Financial, Raymond James, Royal Bank of Canada, Scotiabank, Stifel Nicolaus, TD Securities, and Ventum Financial.
View the latest analyst ratings for WELL.

What is the current price target for WELL Health Technologies?

0 Wall Street analysts have set twelve-month price targets for WELL Health Technologies in the last year. Their average twelve-month price target is C$8.28, suggesting a possible upside of 16.6%. Raymond James has the highest price target set, predicting WELL will reach C$11.00 in the next twelve months. Royal Bank of Canada has the lowest price target set, forecasting a price of C$5.50 for WELL Health Technologies in the next year.
View the latest price targets for WELL.

What is the current consensus analyst rating for WELL Health Technologies?

WELL Health Technologies currently has 1 hold rating and 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for WELL.

What other companies compete with WELL Health Technologies?

How do I contact WELL Health Technologies' investor relations team?

WELL Health Technologies' physical mailing address is 4500 Dorr St, Toledo, Ohio 43615-4040. The company's listed phone number is 604 628 7266. The official website for WELL Health Technologies is www.well.company. Learn More about contacing WELL Health Technologies investor relations.